Cargando…
Systemic antibiotic sales and WHO recommendations, India
OBJECTIVE: To analyse sales of fixed-dose combination and single antibiotics in India in relation to World Health Organization (WHO) recommendations and national regulatory efforts to control antibiotic sales. METHODS: We extracted data on sales volumes of systemic antibiotics in India from a market...
Autores principales: | Mehta, Aashna, Brhlikova, Petra, McGettigan, Patricia, Pollock, Allyson M, Roderick, Peter, Farooqui, Habib Hasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511665/ https://www.ncbi.nlm.nih.gov/pubmed/36188020 http://dx.doi.org/10.2471/BLT.22.287908 |
Ejemplares similares
-
Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics
por: Brhlikova, Petra, et al.
Publicado: (2023) -
Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs
por: McGettigan, Patricia, et al.
Publicado: (2015) -
Community level antibiotic utilization in India and its comparison vis-à-vis European countries: Evidence from pharmaceutical sales data
por: Farooqui, Habib Hasan, et al.
Publicado: (2018) -
Does price regulation affect atorvastatin sales in India? An impact assessment through interrupted time series analysis
por: Selvaraj, Sakthivel, et al.
Publicado: (2019) -
Evaluating the impact of price regulation (Drug Price Control Order 2013) on antibiotic sales in India: a quasi-experimental analysis, 2008–2018
por: Selvaraj, Sakthivel, et al.
Publicado: (2022)